Company / Tangible Book Value per Share
AGIOS PHARMACEUTICALS, INC. Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$20.87
FY2025
5-year range
$7.35 / $27.54
FY2021-FY2025
Trend
-24.2%
vs FY2024
Sector context
#25 of 209
Health Care
What the data says
AGIOS PHARMACEUTICALS, INC.'s tangible book value per share of $20.87 is higher than 88% of companies in the Health Care sector (FY2025). Tangible Book Value per Share has fluctuated over the past 10 years, ranging from $7.34 in FY2018 to $27.54 in FY2024.
Based on SEC 10-K filings.
20.87 in FY2025 with a 5-year CAGR of +15.7%. Top quartile in the Health Care sector.
Improved from $14.74 to $20.87 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- +41.6%
- 5-Year CAGR
- +15.7%
- 10-Year CAGR
- -
Sector benchmark
-82.6% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share decreased 24.2% year-over-year.
- Ranks #25 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2024.
- Lowest tangible book value per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.83 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $20.87 | -24.2% |
| FY2024 | $27.54 | +86.9% |
| FY2023 | $14.74 | +100.4% |
| FY2022 | $7.35 | -65.6% |
| FY2021 | $21.37 | +112.6% |
| FY2020 | $10.05 | -8.6% |
| FY2019 | $11.00 | +49.8% |
| FY2018 | $7.34 | -17.4% |
| FY2017 | $8.89 | -6.5% |
| FY2016 | $9.51 | +168.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026